Trimetrexate
At a glance
- Drug Originator Pfizer
- Drug Licenced by Ipsen; MedImmune Oncology; MegaPharm Ltd; Merck & Co; Swedish Orphan Biovitrum
- Drug Class Antineoplastics; Antiprotozoals; Quinazolines
- Mechanism of Action Tetrahydrofolate dehydrogenase inhibitors
- USA Patent Applicants MEDIMMUNE ONCOLOGY
- USA Patents 3
- NDAs 1
Table of Contents
Disclaimer